Haleon plc (HLNCF)
OTCMKTS
· Delayed Price · Currency is USD
4.690
-0.330 (-6.57%)
Aug 14, 2025, 1:24 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Oral Health | 3.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Health Growth | 3.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins, Minerals and Supplement | 1.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins, Minerals and Supplement Growth | -0.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pain Relief | 2.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pain Relief Growth | -0.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Health Revenue (Pre-FY2025 Reporting) | 1.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Health Revenue (Pre-FY2025 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive Health and Other Revenue (Pre-FY2025 Reporting) | 1.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive Health and Other Revenue (Pre-FY2025 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| North America | 4.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -4.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm | 4.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm Growth | -2.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC | 2.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Growth | 1.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| North America Adjusted Operating Profit | 1.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm Adjusted Operating Profit | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Adjusted Operating Profit | 539.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Profit | -93.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Organic Revenue Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales Growth due to Price | 3.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales Growth due to Volume/Mix | 1.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|